Plasma Metabolomic Signatures Associated with Long-term Breast Cancer Risk in the SU.VI.MAX Prospective Cohort

Published on Jan 1, 2019in Cancer Epidemiology, Biomarkers & Prevention4.344
· DOI :10.1158/1055-9965.EPI-19-0154
Lucie Lécuyer9
Estimated H-index: 9
(Sorbonne),
Céline Dalle4
Estimated H-index: 4
(INRA: Institut national de la recherche agronomique)
+ 18 AuthorsMathilde Touvier68
Estimated H-index: 68
(Sorbonne)
Sources
Abstract
Background:Breast cancer is a major cause of death in occidental women. The role of metabolism in breast cancer etiology remains unclear. Metabolomics may help to elucidate novel biological pathways and identify new biomarkers in order to predict breast cancer long before symptoms appear. The aim of this study was to investigate whether untargeted metabolomic signatures from blood draws of healthy women could contribute to better understand and predict the long-term risk of developing breast cancer. Methods:A nested case-control study was conducted within the SU.VI.MAX prospective cohort (13 years of follow-up) to analyze baseline plasma samples of 211 incident breast cancer cases and 211 matched controls by LC-MS mass spectrometry. Multivariable conditional logistic regression models were computed. Results:3565 ions were detected and 1221 were retained for statistical analysis. 73 ions were associated with breast cancer risk (p<0.01, FDR≤0.2). Notably, we observed that a lower plasma level of O-succinyl-homoserine (0.70[0.55-0.89]) and higher plasma levels of valine/norvaline (1.45[1.15-1.83]), glutamine/isoglutamine (1.33[1.07-1.66]), 5-aminovaleric acid (1.46[1.14-1.87]), phenylalanine (1.43[1.14-1.78]), tryptophan (1.40[1.10-1.79]), γ-glutamyl-threonine (1.39[1.09-1.77]), ATBC (1.41[1.10-1.79]) and pregnene-triol sulfate (1.38[1.08-1.77]) were associated with an increased risk of developing breast cancer during follow-up. Conclusions:Several pre-diagnostic plasmatic metabolites were associated with long-term breast cancer risk and suggested a role of microbiota metabolism and environmental exposure. Impact:After confirmation in other independent cohort studies, these results could help to identify healthy women at higher risk of developing breast cancer in the subsequent decade and to propose a better understanding of the complex mechanisms involved in its etiology.
📖 Papers frequently viewed together
2013
5 Authors (Jie Shen, ..., Hua Zhao)
5 Authors (Jie Shen, ..., Hua Zhao)
42 Citations
2009
4 Authors (David G. Cox, ..., Paul Pharoah)
2 Citations
References47
Newest
#1Freddie Bray (IARC: International Agency for Research on Cancer)H-Index: 119
#1Freddie Bray (IARC: International Agency for Research on Cancer)H-Index: 18
Last. Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
view all 6 authors...
This article provides a status report on the global burden of cancer worldwide using the GLOBOCAN 2018 estimates of cancer incidence and mortality produced by the International Agency for Research on Cancer, with a focus on geographic variability across 20 world regions. There will be an estimated 18.1 million new cancer cases (17.0 million excluding nonmelanoma skin cancer) and 9.6 million cancer deaths (9.5 million excluding nonmelanoma skin cancer) in 2018. In both sexes combined, lung cancer...
31.7k CitationsSource
Background: Elevated body mass index (BMI) is associated with increased risk of postmenopausal breast cancer. The underlying mechanisms, however, remain elusive. Methods: In a nested case-control study of 621 postmenopausal breast cancer case participants and 621 matched control participants, we measured 617 metabolites in prediagnostic serum. We calculated partial Pearson correlations between metabolites and BMI, and then evaluated BMI-associated metabolites (Bonferroni-corrected α level for 61...
42 CitationsSource
#1Nada Assi (IARC: International Agency for Research on Cancer)H-Index: 12
#2Duncan C. Thomas (SC: University of Southern California)H-Index: 77
Last. Vivian Viallon (IARC: International Agency for Research on Cancer)H-Index: 20
view all 22 authors...
Background: The “meeting-in-the-middle” (MITM) is a principle to identify exposure biomarkers that are also predictors of disease. The MITM statistical framework was applied in a nested case–control study of hepatocellular carcinoma (HCC) within European Prospective Investigation into Cancer and Nutrition (EPIC), where healthy lifestyle index (HLI) variables were related to targeted serum metabolites. Methods: Lifestyle and targeted metabolomic data were available from 147 incident HCC cases and...
13 CitationsSource
#1Lucie Lécuyer (Sorbonne)H-Index: 9
#2Agnès Victor Bala (CNRS: Centre national de la recherche scientifique)H-Index: 1
Last. Mathilde Touvier (Sorbonne)H-Index: 68
view all 18 authors...
Background: Combination of metabolomics and epidemiological approaches opens new perspectives for groundbreaking discoveries. The aim of the present study was to investigate for the first time whether plasma non-targeted metabolomic profiles, established from a simple blood draw from healthy women, could contribute to predict the risk of developing breast cancer within the following decade and to better understand the aetiology of this complex disease. Methods: A prospective nested case-control ...
25 CitationsSource
#1Qin Wang (University of Oulu)H-Index: 14
#2Michael V. Holmes (UoB: University of Bristol)H-Index: 52
Last. Mika Ala-Korpela (UoB: University of Bristol)H-Index: 71
view all 4 authors...
OBJECTIVE Insulin resistance has deleterious effects on cardiometabolic disease. We used Mendelian randomization analyses to clarify the causal relationships of insulin resistance (IR) on circulating blood-based metabolites to shed light on potential mediators of the IR to cardiometabolic disease relationship. RESEARCH DESIGN AND METHODS We used 53 single nucleotide polymorphisms associated with IR from a recent genome-wide association study (GWAS) to explore their effects on circulating lipids ...
76 CitationsSource
#1Mary C. Playdon (Yale University)H-Index: 21
#2Regina G. ZieglerH-Index: 81
Last. Steven C. MooreH-Index: 55
view all 9 authors...
Background: The epidemiologic evidence for associations between dietary factors and breast cancer is weak and etiologic mechanisms are often unclear. Exploring the role of dietary biomarkers with metabolomics can potentially facilitate objective dietary characterization, mitigate errors related to self-reported diet, agnostically test metabolic pathways, and identify mechanistic mediators. Objective: The aim of this study was to evaluate associations of diet-related metabolites with the risk of ...
77 CitationsSource
#1Lindsay M. Rasmussen (UA: University of Arizona)H-Index: 2
#2Nivedita Sen (UA: University of Arizona)H-Index: 12
Last. Zelieann R. Craig (UA: University of Arizona)H-Index: 15
view all 5 authors...
: Dibutyl phthalate (DBP) is present in consumer products and the coating of some oral medications. Acetyl tributyl citrate (ATBC) has been proposed as an alternative to DBP because DBP causes endocrine disruption in animal models. Following ingestion, DBP is converted to its main metabolite mono-butyl phthalate (MBP) which has been detected in >90% of human follicular fluid samples. Previous studies show that DBP reduces the number of antral follicles present in the ovaries of mice. Thus, this ...
26 CitationsSource
#1Olha Zhenyukh (UAM: Autonomous University of Madrid)H-Index: 6
#2Esther Civantos (UAM: Autonomous University of Madrid)H-Index: 6
Last. Sebastian Mas (UAM: Autonomous University of Madrid)H-Index: 22
view all 8 authors...
Abstract Leucine, isoleucine and valine are essential aminoacids termed branched-chain amino acids (BCAA) due to its aliphatic side-chain. In several pathological and physiological conditions increased BCAA plasma concentrations have been described. Elevated BCAA levels predict insulin resistance development. Moreover, BCAA levels higher than 2 mmol/L are neurotoxic by inducing microglial activation in maple syrup urine disease. However, there are no studies about the direct effects of BCAA in c...
119 CitationsSource
#1Jiaqi HuangH-Index: 13
#2Alison M. Mondul (UM: University of Michigan)H-Index: 41
Last. Demetrius AlbanesH-Index: 127
view all 10 authors...
Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial
34 CitationsSource
#1Magdalena Stepien (IARC: International Agency for Research on Cancer)H-Index: 25
#2Talita Duarte-Salles (IARC: International Agency for Research on Cancer)H-Index: 27
Last. Mazda Jenab (IARC: International Agency for Research on Cancer)H-Index: 93
view all 48 authors...
Perturbations in levels of amino acids (AA) and their derivatives are observed in hepatocellular carcinoma (HCC). Yet, it is unclear whether these alterations precede or are a consequence of the disease, nor whether they pertain to anatomically related cancers of the intrahepatic bile duct (IHBC), and gallbladder and extrahepatic biliary tract (GBTC). Circulating standard AA, biogenic amines and hexoses were measured (Biocrates AbsoluteIDQ-p180Kit) in a case-control study nested within a large p...
48 CitationsSource
Cited By13
Newest
#1Jonathan B. Thacker (UM: University of Michigan)
#1Jonathan B. Thacker (UM: University of Michigan)H-Index: 5
Last. Subramaniam Pennathur (UM: University of Michigan)H-Index: 45
view all 3 authors...
γ-Glutamylpeptides have been identified as potential biomarkers for a number of diseases including cancer, diabetes, and liver disease. In this study, we developed and validated a novel quantitative analytical strategy for measuring γ-glutamylisoleucine, γ-glutamylthreonine, and γ-glutamylvaline, all of which have been previously reported as potential biomarkers for prostate cancer, in HeLa cells using UHPLC-MS/MS. A BEH C18 column was used as the stationary phase. Mobile phase A was 99:1 water:...
Source
#1Jiaomei Li (Qingdao University)H-Index: 7
#2Zhaohong Zheng (Qingdao University)
Last. Duo Li (Qingdao University)H-Index: 58
view all 6 authors...
The present study aimed to investigate the relationship between the n-3 index, serum metabolites and breast cancer risk. A total of 104 newly diagnosed breast cancer patients and 70 healthy controls were recruited. The erythrocyte phospholipid fatty acid composition was determined by gas-liquid chromatography, and the n-3 index was calculated with the percentage of eicosapentaenoic acid plus docosahexaenoic acid in total fatty acids. Serum metabolomic profiles were analyzed by UHPLC-Q-Exactive O...
Source
#1Oana A. Zeleznik (Brigham and Women's Hospital)H-Index: 11
#2Raji Balasubramanian (UMass: University of Massachusetts Amherst)H-Index: 17
Last. A. Heather Eliassen (Harvard University)H-Index: 60
view all 9 authors...
Known modifiable risk factors account for a small fraction of premenopausal breast cancers. We investigated associations between pre-diagnostic circulating amino acid and amino acid-related metabolites (N = 207) and risk of breast cancer among predominantly premenopausal women of the Nurses' Health Study II using conditional logistic regression (1057 cases, 1057 controls) and multivariable analyses evaluating all metabolites jointly. Eleven metabolites were associated with breast cancer risk (q-...
Source
#1Elodie Jobard (UCBL: Claude Bernard University Lyon 1)H-Index: 7
#2Laure Dossus (IARC: International Agency for Research on Cancer)H-Index: 68
Last. Joseph A Rothwell (Université Paris-Saclay)
view all 12 authors...
BACKGROUND Perturbations in circulating metabolites prior to a breast cancer diagnosis are not well characterised. We aimed to gain more detailed knowledge to help understand and prevent the disease. METHODS Baseline plasma samples from 791 breast cancer cases and 791 matched controls from the E3N (EPIC-France) cohort were profiled by nuclear magnetic resonance (NMR)-based untargeted metabolomics. Partial least-squares discriminant analysis (PLS-DA) models were built from NMR profiles to predict...
1 CitationsSource
#1L. Lécuyer (University of Paris)H-Index: 1
#1Lucie Lécuyer (University of Paris)H-Index: 9
Last. Mathilde Touvier (University of Paris)H-Index: 68
view all 17 authors...
INTRODUCTION Prostate cancer is a multifactorial disease whose aetiology is still not fully understood. Metabolomics, by measuring several hundred metabolites simultaneously, could enhance knowledge on the metabolic changes involved and the potential impact of external factors. OBJECTIVES The aim of the present study was to investigate whether pre-diagnostic plasma metabolomic profiles were associated with the risk of developing a prostate cancer within the following decade. METHODS A prospectiv...
1 CitationsSource
#1Oana A. Zeleznik (Brigham and Women's Hospital)H-Index: 11
#2Raji Balasubramanian (UMass: University of Massachusetts Amherst)H-Index: 17
Last. A. H. Eliassen (Brigham and Women's Hospital)
view all 12 authors...
Abstract Circulating branched chain amino acid (BCAA) levels reflect metabolic health as well as dietary intake and have been linked to some cancers. Associations with breast cancer are unclear. We evaluated the association between circulating BCAA levels and risk of breast cancer in a prospective nested case-control study (1,997 cases, 1,997 controls) within the Nurses’ Health Study (NHS) and NHSII. Two-thirds of women in NHS (592 cases) donated two blood samples collected 10 years apart. We us...
1 CitationsSource
#1Manmohan MitrukaH-Index: 1
Last. Nilesh Kumar SharmaH-Index: 10
view all 5 authors...
BACKGROUND: Metabolic reprogramming in breast cancer is depicted as a crucial change in the tumor microenvironment. Besides the molecular understanding of metabolic heterogeneity, appreciable attentions are drawn to characterize metabolite profiles in tumor tissue and derived biological fluids and tissue materials. Several findings reported on the metabolic alterations of free aromatic amino acids (FAAAs) and other metabolites in biological fluids. Furthermore, there is a significant gap in the ...
3 CitationsSource
#2Marcella Regina Cardoso (State University of Campinas)H-Index: 2
Last. Andreia M. PorcariH-Index: 9
view all 13 authors...
Plasma and tissue from breast cancer patients are valuable for diagnostic/prognostic purposes and are accessible by multiple mass spectrometry (MS) tools. Liquid chromatography-mass spectrometry (LC-MS) and ambient mass spectrometry imaging (MSI) were shown to be robust and reproducible technologies for breast cancer diagnosis. Here, we investigated whether there is a correspondence between lipid cancer features observed by desorption electrospray ionization (DESI)-MSI in tissue and those detect...
3 CitationsSource
#1Alessia Vignoli (UniFI: University of Florence)H-Index: 11
#2Elena MuraroH-Index: 14
Last. Giuseppe CoronaH-Index: 27
view all 9 authors...
HER2-positive breast cancer (BC) represents a heterogeneous cancer disease. In an attempt to identify new stratification models useful for prognosis and therapeutic strategy, we investigated the influence of estrogen receptor (ER) status on the host immune and metabolomics profile of HER2-positive BC patients enrolled for neoadjuvant targeted chemotherapy (NATC). The study enrolled 43 HER2-positive BC patients eligible for NATC based on the trastuzumab-paclitaxel combination. Baseline circulator...
7 CitationsSource
#1Lucie Lécuyer (Sorbonne)H-Index: 9
#2Céline Dalle (INRA: Institut national de la recherche agronomique)H-Index: 4
Last. Mathilde Touvier (Sorbonne)H-Index: 68
view all 22 authors...
Purpose Dietary intakes are reflected in plasma by the presence of hundreds of exogenous metabolites and variations in endogenous metabolites. The exploration of diet-related plasma metabolic profiles could help to better understand the impact of overall diet on health. Our aim was to identify metabolomic signatures reflecting overall diet in women from the French general population.
5 CitationsSource